December 3 Product: Biocon Biologics Yesintek Indication: Crohns disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis The FDA on Monday signed off on Biocon Biologics Yesintek (ustekinumab-kfce), a biosimilar to Johnson & Johnsons blockbuster antibody Stelara
La fiabilidad de los pagos es otro pilar
A challenge during the early development of GLP-1-based therapy was its short half-life in the circulation (approximately 2 min after i.v
At 10 mg/mL, where a 0.25 mg dose is 2.5 units, a 30-unit syringe lets you draw to the fifth tick mark with confidence
Peptide Pills for Weight Loss: Evidence, Risks and NHS Options Peptide pills for weight loss are increasingly marketed online and in health shops as natural or scientifically advanced alternatives to prescription treatments
Cardiovascular outcomes During accumulated follow-up time totaling approximately 39.0 person-years, three expanded MACE events were observed, yielding an incidence rate of 7.69 events per 100 person-years